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Abstract Motor disability in MS is commonly assessed
by the Expanded Disability Status Scale (EDSS). Cate-
gorical rating scales are limited by subjective error and
inter-rater variability. Therefore, objective and quantitative
measures of motor disability may be useful to supplement
the EDSS in the setting of clinical trials. It was previously
shown that grip-force-variability (GFV) is increased in MS.
We hypothesized that GFV may be an objective measure of
motor disability in MS. To investigate whether the increase
in GFV in MS is correlated to the clinical disability as
assessed by the EDSS and to microstructural changes in the
brain as assessed by diffusion tensor imaging, GFV was
recorded in a grasping and lifting task in 27 MS patients
and 23 controls using a grip-device equipped with a force
transducer. The EDSS was assessed by neurologists expe-
rienced in MS. Patients underwent diffusion tensor imaging
at 3T to assess the fractional anisotropy (FA) of the cere-
bral white matter as a measure of microstructural brain
integrity. GFV was increased in MS and correlated to
changes in the FA of white matter in the vicinity of the
somatosensory and visual cortex. GFV also correlated with
the EDSS. GFV may be a useful objective measure of
motor dysfunction in MS linked to disability and structural
changes in the brain. Our data suggests that GFV should be
further explored as an objective measure of motor dys-
function in MS. It could supplement the EDSS, e.g., in
proof of concept studies.
Keywords Multiple sclerosis  DTI  Clinical
neurophysiology  Outcome research
Introduction
Multiple sclerosis (MS) is an autoimmune central nervous
system disorder resulting in demyelination and subsequent
neuroaxonal damage. Impairments in motor coordination
and loss of sensory perception are common in all forms of
MS [4]. In clinical settings, disability—including sensory-
motor dysfunction—is usually assessed by the Expanded
Disability Status Scale (EDSS) [26], which frequently
serves as outcome measure in clinical trials [27]. However,
the EDSS is a clinical rating scale confined by inter- and
intra-rater variability and limited sensitivity due to its
categorical nature [16]. In contrast, supplementary objec-
tive and quantitative measures of motor dysfunction may
improve the sensitivity of motor phenotype assessment in
clinical trials, e.g., by reducing cohorts required to suffi-
ciently power proof of concept studies.
Manipulation of objects in the precision grip (between
thumb and index finger) is a motor task with high func-
tional relevance in everyday life. Assessment of grip forces
during grasping and lifting paradigms was able to objec-
tively and quantitatively detect deficits in subjects with MS
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[28]. This was confirmed independently [24, 25]. Increased
variability of motor performance, expressed by the vari-
ability of grip forces during a static holding phase, was a
finding reported across all of these studies [24, 25, 28].
However, it is unknown whether changes in grip force
variability (GFV) are correlated to the severity of motor
symptoms and linked to changes observed in the brains of
MS subjects. Several MRI techniques have been estab-
lished to assess disease burden in the brains of subjects
with MS; diffusion tensor imaging (DTI) has evolved as a
reliable method to detect and monitor microstructural brain
tissue damage in MS (for review see [9]). DTI was previ-
ously shown to correlate to clinical disability in MS [34,
41, 44] and is considered a promising imaging endpoint for
proof of concept studies [11]. A DTI measure of anisotropy
frequently applied in neurology and particularly in MS is
‘‘fractional anisotropy’’ (FA) (e.g., [2, 5, 6, 9]), which was
predefined as a primary DTI outcome measure in this
study.
We therefore decided to investigate whether changes in
GFV are correlated to the disability detected in the EDSS
and to changes of FA in DTI as a measure of microstruc-
tural white matter integrity. We hypothesized that GFV is
(1) increased in subjects with MS compared to healthy
controls, (2) correlated to disease severity and clinical
disability as assessed by the EDSS, and (3) correlated to
changes in FA as assessed by DTI.
Subjects and methods
Subjects
Twenty-seven subjects with MS according to the revised
McDonald Criteria [36] (15 relapsing–remitting—RRMS,
8 secondary-progressive—SPMS, 4 primary-progressive
MS—PPMS), 9 males and 18 females, mean age
39.3 ± 10.3 (all values mean ± SD, range 24–61), and 23
healthy control subjects, 7 males and 16 females, mean age
38.4 ± 9.3 (range 24–55) participated in the study after
giving their written informed consent in accordance with
the Declaration of Helsinki. Median EDSS was 4 (range
1–6.5). Exclusion criteria were: coexisting neurological
diseases, orthopaedic disorders, or other impairments
interfering with task performance. Control subjects had no
neurological or psychiatric diseases and neurological
examination was normal.
Experimental setup and motor task
Quantitative motor assessment was performed using a grip
device (250 g) (see Fig. 1a) that was grasped and lifted in
the precision grip between thumb and index finger as
described before [37]. In brief, a pre-calibrated force
transducer covered with 200-grit sandpaper (Nano 40, ATI,
USA) measured grip and lift forces (0.025 N resolution) of
the thumb. An electromagnetic 3D-sensor (Fastrack, Pol-
hemus, USA) assessed the position of the device. Ten trials
were performed after completion of three test trials. Once
lifted, subjects held the object stable close to a marker
located 10 cm above the table for 30 s.
The mean isometric grip force (GF[N]) and grip force
variability (GFV, expressed as coefficient of varia-
tion = SD/GF 9 100 [%]) were assessed during the static
holding phase, which was pre-defined as the period from
second 8 to 30 in each trial to exclude changes in the forces
occurring during lift initiation (see Fig. 1b). Grip force
assessments were performed in the morning to ensure that
measurements were not affected by fatigue. The mean
value of all ten trials was used for further analysis. Patients
not able to perform all ten trials were excluded from the
study. The task was performed using the right hand
Fig. 1 Quantitative motor
assessment of multiple sclerosis
using grip force variability
method. a Grip device with
force transducer and position
sensor; b sample recordings of a
control subject, a mild and
severely affected patient with
MS
408 J Neurol (2013) 260:407–414
123
(dominant in 26 patients and 21 controls). Control subjects
also performed the task using their left hand. Measures
were not different between the dominant and nondominant
hand (p = 0.15 for GFV; p = 0.53 for GF; paired t test).
Therefore we decided to also include the two left-handed
controls and the one left-handed MS subject to increase
statistical power.
DTI protocol
Twenty-three of the 27 MS patients underwent DTI. The
remaining four did not tolerate the scan. MRI was per-
formed using a 3T whole-body scanner (Gyroscan Intera
T30, Philips, the Netherlands). Data were acquired using a
single shot echo planar imaging (EPI) sequence in 72
axial slices (1.8 mm thick, no gap, FOV 230 9 230 mm,
acquired matrix 127 9 128, b factors: 0 and 1,000 s/mm2
6 gradient directions, 3 averages). For further process-
ing all EPI images were reconstructed to 2.0 9
2.0 9 2.0 mm3. All images were spatially registered by
the multicontrast image registration toolbox for optimal
spatial pre-processing of DTI data prior to statistical
analysis [29] and corrected for eddy currents in all three
dimensions using a recently developed technique [6, 30].
After image registration all DTI images corresponded to
the Montreal Neurological Institute (MNI) coordinate
space.
In DTI microstructural brain tissue, alterations are fre-
quently described by FA changes as the primary outcome
measure [9]. However the FA is not the only parameter
used for describing diffusion properties of brain tissue. FA
is calculated from the three tensor eigenvalues k1, k2, and
k3 and is sensitive to differences between these tensor
invariants: FA = sqrt((k1 - k2)
2 ? (k2 - k3)





2)) [5]. The largest eigenvalue k1
represents the apparent diffusion coefficient in direction of
strongest (main) diffusion and is also denoted as axial
diffusivity (AD). The eigenvalues k2 and k3 describe the
diffusion perpendicular to the main diffusion direction
and can be summarized as the radial diffusivity
RD = (k2 ? k3)/2. The average of all three eigenvalues is
denominated as mean diffusivity MD = (k1 ? k2 ? k3)/3
[1].
We calculated FA (predefined primary DTI outcome
measure), AD, MD, and RD images of all patients and
applied voxel-based statistics (VBS) using SPM (http://
www.fil.ion.ucl.ac.uk/spm) to investigate the correlation
between these four parameters and GFV on a voxel-by-
voxel basis (4 mm FWHM, p \ 0.01, corrected). In addi-
tion, we employed a region of interest (ROI)-based
regression analysis to assess FA, AD, MD, and RD changes
in relation to the patients’ GFV. The ROI was defined post
hoc on the basis of the SPM results.
Data processing and statistical analysis
of behavioural data
Data was recorded (sampling rate of 400 Hz) and pro-
cessed using a flexible data acquisition system (SC/ZOOM,
Department of Physiology, University of Umea, Sweden).
Statistical analysis was performed using SPSS14. Stu-
dent’s t test was calculated for intergroup comparisons
between MS subjects and controls, the paired t test was
used for intragroup comparisons; Pearson’s correlation
coefficients were calculated to analyse correlations of GF
and GFV with the EDSS. Statistical significance was
assumed at p B 0.05. Results were expressed in
means ± standard-error-of-mean (SEM).
Results
Intergroup comparisons
GFV was significantly increased in subjects with MS com-
pared to controls (5.2 ± 0.4 % vs. 3.6 ± 0.3 %; p = 0.005)
(see Fig. 2a). The mean applied GF did not differ signifi-
cantly between groups (3.4 ± 0.3 N vs. 4.2 ± 0.4 N;
p = 0.13). To determine the test–retest reliability of GFV, we
calculated the intraclass correlation coefficient (ICC) of mean
GFV measures across all ten trials in the MS group (see
Fig. 2c). The ICC showed a robust agreement across trials
(r = 0.89, p \ 0.0001). We also calculated the ICC for the
first and last five trials, respectively, to account for possible
fatigue effects. We did not find significant differences
between the two trial groups (r = 0.82 for the first five trials;
r = 0.81 for the last five trials; p \ 0.0001). Figure 2c
visually implies that the last two trials might show an
increased GFV compared to baseline. However, statistical
analysis revealed no difference in GFV between the first and
the two last trials (p = 0.56 for trial 1 vs. 10; p = 0.29 for
trial 1 vs. 9; paired t test). We also investigated the relation-
ship of grip force measures and age. Neither GF nor GFV
were correlated with age in any of the groups (GF: r = 0.12,
p = 0.55; GFV: r = 0.003, p = 0.98 for the MS group; GF:
r = 0.29, p = 0.17; GFV = 0.29, p = 0.17 for the controls).
Correlation of measures with the EDSS
GFV correlated significantly with the patients’ EDSS
(r = 0.41; p \ 0.04) (see Fig. 2b). Mean GF did not cor-
relate with the EDSS (r = -0.2; p = 0.92).
Correlation of GFV with FA, AD, RD, and MD
The voxel-level SPM analysis revealed that GFV cor-
related significantly with regional FA of the white
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matter in several regions bilaterally (see Fig. 3a, b).
Significant correlations between GFV and FA were
found in the white matter regions associated to the
primary somatosensory cortex. Additionally, we found
strong correlations between GFV and FA of white
matter in the vicinity of the visual cortex, whereas no
correlations between GFV and FA could be observed in
the white matter adjacent to the primary motor cortex
or in the frontal white matter. Representative regression
of GFV and FA across a ROI encompassing an area of
high correlation in the left hemisphere (r = -0.70;
p \ 0.0003) is shown in Fig. 3c. Voxel-level analysis
revealed no correlation between GFV and AD, RD, and
MD after correction for multiple comparisons
(p [ 0.05). Thus, a ROI outlining prominent regions of
significant correlations between GFV and AD, RD, and
MD could not be defined. GFV did not significantly
(p [ 0.05) correlate with AD, RD, and MD in the
ROI used for assessing quantitative FA changes
(Fig. 3c), although trends for weak correlations
were observed (rAD = 0.34, pAD = 0.11; rRD = 0.37,
pRD \ 0.09; rMD = 0.36, pMD \ 0.09) as shown in
Fig. 3d–f. Mean GF did not correlate with FA, AD, RD,
and MD, neither at the whole brain level nor in the
ROI analysis.
Discussion
This study demonstrates that GFV is increased in subjects
with MS. The amplitude of increase is correlated to the
clinical disability as assessed by the EDSS and to micro-
structural changes in the brain measured by the FA of DTI
of the central white matter. Furthermore, intraclass corre-
lation analysis revealed a high test–retest reliability of the
GFV assessment. We therefore confirmed our hypotheses
and conclude that our results support a link between
quantitative motor deficits, disability and structural chan-
ges in subjects with MS.
While increased GFV in MS was described previously
in smaller cohorts [24, 25], this study is the first to dem-
onstrate a link between GFV and changes in imaging and
the EDSS. Assessment of DTI has been intensely studied in
MS in order to provide an objective outcome measure of
microstructural brain damage for clinical trials (e.g., [8, 11,
41, 44]). The direct link to brain pathology makes DTI
particularly compelling for assessing novel measures such
as GFV; a similar strategy has recently been applied to
provide evidence for a link of oculomotor deficits to
changes in DTI [12]. In another study, FA and individual
radial diffusivities proved to be important markers of motor
disabilities in MS patients, and FA exhibited a correlation
Fig. 2 Grip force variability
(GFV) in MS is increased
compared to controls and
correlated to the EDSS.
a Increased GFV in MS patients
compared to controls;
b correlation of GFV and the
EDSS; c intraclass correlation
(ICC) of mean GFV measures
across all ten trials in the MS
group showed high agreement
across trials (r = 0.89;
p \ 0.0001) indicating a high
test–retest reliability of GFV
(see text for details); bars
indicate the standard error of
mean
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Fig. 3 Link between structure and function: quantitative motor deficits
are correlated to changes in FA. a Significant correlations between white
matter FA reduction and GFV were found in areas associated with the
primary somatosensory cortex and in the vicinity of the visual cortex
(p \ 0.0001, corrected for multiple comparisons, minimal cluster size
1,000 voxel, orange rendered regions represent t values between 1.72
and 6.11); b glass brain showing the areas of correlation; c regression
analysis in ROI (post hoc) depicting high correlation between FA and
GFV in the left hemisphere—see green area on right inlay—respective
regions on both inlay images are marked by red circles; d–f regression
analyses in the same ROI for AD, RD and MD are not significant
(p [ 0.05), but exhibit weak trends for all measures as may be
appreciated in the plots. The biological meaning of these observations
needs to be re-addressed in larger studies (AD axial diffusivity, a.u.
arbitrary units, FA fractional anisotropy, GFV grip force variability, MD
mean diffusivity, RD radial diffusivity)
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with the EDSS [34]. Interestingly, in our study the corre-
lation of the GFV with FA was stronger than with the
EDSS. This may be explained by the quantitative and
objective nature of both GFV and FA, while the EDSS is
categorical and may be influenced by intra- and inter-rater
variability. In addition, the EDSS does not specifically
assess fine motor control of the hand. We also acknowledge
that the EDSS is influenced by spinal pathology, which is
not assessed by brain FA. Notably, although we observed a
trend towards a weak correlation of GFV and individual
diffusivity measures (i.e., AD, MD, and RD) in the ROI
exhibiting highest correlation with FA, only FA signifi-
cantly correlated with behavioural measures, suggesting
that FA may be the most sensitive DTI measure to detect
microstructural white matter damage associated with grip
force control in our patient sample. However, statistically
significant correlations of AD, MD, or RD with GFV might
be observed in a larger cohort.
Appropriate coordination of upper extremities including
grasping of objects is required for various tasks of daily
living and impairments are linked to functional decline in
MS [7]. The mechanisms governing grip force control in
precision grasping are complex [20]. Permanent updating
of afferent information is required to adjust motor output
[21, 22]. Part of this afferent feedback is provided by
mechanoreceptors in the skin of the digits [13, 43]. Lack of
sensory information from the grasping fingers has been
shown to cause a disturbance of grip force scaling [19, 32,
33]. In addition, vision is an important source of afferent
information about the object’s characteristics and is used to
adjust motor commands prior to the lift and during the grip
[14, 17], affecting ‘‘feed-forward’’ mechanisms [31] and
maintenance of stable grip forces during task performance
[39]. The key importance of sensory and visual feedback
mechanisms for grip force control suggests that both
peripheral and central pathology in these neuronal path-
ways may disrupt force coordination [18]. Interestingly
significant correlations between GFV and FA changes in
our cohort were primarily localized to the white matter in
the vicinity of the somatosensory and visual cortex, as
shown in Fig. 3a, b. Afferent visual pathways are com-
monly affected in MS [23, 35] and changes in the white
matter of the occipital, parietal and temporal lobes are seen
across different forms of MS [3, 42]. Notably, neither GFV
nor the mean applied grip force was correlated to white
matter changes in regions associated to the primary motor
cortex and the mean grip force applied by MS patients was
not changed compared to controls. This implies that the
increase in GFV in our cohort of subjects was not caused
by central paresis but rather due to deficits in the coordi-
nation of force output.
However, we acknowledge that this study has several
limitations. The correlation analyses performed between
FA changes and GFV do not allow a firm conclusion about
causal relationships between the affected brain regions and
the motor measures. The findings reported above need to be
reproduced in a larger cohort of subjects. The regional
distribution of changes in FA observed may still be due to
selection bias in the group of patients investigated. One
obvious limitation is based on the fact that subjects
enrolled in this study still need to be capable of grasping
and holding the object used. Nevertheless, it seems likely
that the deficits in motor performance observed in the
measured GFV are at least partly due to the described white
matter pathology. We also acknowledge that the patients in
our study were recruited irrespective of a relapsing or
chronic progressive form of MS. However, although there
is evidence that severity and localization of white matter
damage differs across MS subtypes [9], it is known that FA
detects white matter changes in all subtypes of MS [8]. Due
to the limited sample size of our cohort, reliable subgroup
analyses could not be performed in this study. In addition,
we report cross-sectional analyses only. While the corre-
lation of GFV changes with the EDSS and with white
matter, pathology intuitively suggests that GFV may also
be used to measure progression of phenotype; this needs to
be investigated in a prospective follow-up study. Future
studies should also include the MS functional composite
score and the nine-hole-peg-test (NHPT), which may pro-
vide more sensitive information about fine motor control
than the EDSS [10].
In this context it seems noteworthy that GFV has evolved
as an objective measure of motor dysfunction in Hunting-
ton’s disease: GFV was increased and correlated to the
UHDRS-total motor score in symptomatic patients [15] and
premanifest gene carriers [37]. GFV increased in the course
of symptomatic Huntington’s disease in a small 3-year single
centre study [38] and this finding was confirmed in a blinded
analysis of quantitative motor data from about 120 patients
and 120 control subjects across 2 years in the multicentre
biomarker study TRACK-HD [40]. These observations
support the feasibility of applying grip force assessments in
the setting of prospective multicentre studies.
We conclude that the results of this study support further
exploration of GFV as an objective measure of motor
disability in MS. Grasping is functionally relevant. The
assessment described can be performed repeatedly in out-
patient settings without risks for subjects. The sensors used
are pre-calibrated, i.e., easily applicable even in multi-
centre settings. Thus, GFV may evolve as a valuable and
sensitive supplemental outcome measure to assess efficacy
and side-effects of novel treatments alongside the EDSS,
particularly in proof of concept studies. The validity of grip
force analysis to assess motor phenotype in MS should be
further elucidated in prospective, blinded multicentre
studies.
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